$SYF

TD Cowen Adjusts Price Target on Synchrony Financial to $86 From $90, Maintains Buy Rating

TD Cowen lowered its price target for Synchrony Financial from $90 to $86 while maintaining a buy rating. The stock is currently trading at $72.74, up 1.20% on the day and down 13.17% over the past year. UBS also recently adjusted its target to $81 from $87, keeping a neutral rating.

Original reporting
Published Oct 6, 2026, 1:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 2:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SYF
Bearish
medium confidence
Mentioned
$SYF
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SYFBearishLow
01

Why it matters

The downgrade may prompt short-term selling pressure but does not indicate a fundamental shift.

02

Market read

Analyst target change provides modest trading insight; limited broader market impact.

03

What to watch

Potential upcoming earnings or macro data could offset the target reduction.

Relevance 5/10Novelty 5/10Timing: today

Background

TD Cowen's research note adjusts its valuation assumptions for Synchrony Financial, a U.S. consumer finance company.

Company-level read

Ticker impact

$SYFBearishMedium confidence
Context

TD Cowen lowered its price target for Synchrony Financial to $86 from $90, indicating a more modest outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Analyst target reductions often precede short-term price declines, especially when no new fundamental data is released.

Market effects

Minimal; the change reflects a modest view on consumer finance sector.

None

Low

Counterpoint

Investors may view the target cut as an overreaction and consider buying on dip.

Key entities

  • Synchrony Financial

    U.S. consumer finance firm (ticker SYF).

  • TD Cowen

    Research firm providing the price target adjustment.

Related articles

$WEAVMed

Weave integrates CareCredit financing into platform

Weave (WEAV) integrated CareCredit financing from Synchrony (SYF) into its platform, allowing healthcare practices to view patient credit status and initiate payments. A survey found 43% of Weave customers would use the service exclusively. The feature aims to streamline payment discussions and processes.

$GNRCMed

GNRC, LEU, AXP, SYF, COF Trending With Analysts

Analysts upgraded Generac (GNRC) to Buy with targets of $280 (KeyBanc) and $303 (Piper Sandler), citing Amazon's $8B deal and data-center growth. Centrus Energy (LEU) initiated at Buy with a $167 target by Guggenheim. American Express (AXP) initiated at Buy with a $380 target, highlighting its fee-based model. Synchrony (SYF) and Capital One (COF) initiated at Hold with $81 and $219 targets, respectively.

$SYFMed

SYF Maintained by UBS -- Price Target Lowered to $81.00

UBS maintained a Neutral rating on Synchrony Financial (SYF) but lowered its price target to $81.00 from $87.00. GuruFocus values SYF at $66.54, suggesting an 8.0% overvaluation. Insiders have sold $847,287 in shares over the past three months. SYF has a GF Score of 89/100, indicating strong performance but with some financial strength concerns.

$SYFMed

No Discount Survives an AI That Can’t See It

Synchrony partnered with OpenAI to integrate promotional financing into ChatGPT, aiming to make store-branded credit cards discoverable. Target already offers AI-driven shopping with loyalty benefits via Microsoft Copilot and ChatGPT, reporting strong digital traffic growth. Visa and Braze executives highlight the importance of AI-readable loyalty programs. Sephora also launched a ChatGPT app for rewards integration. Synchrony's move aims to keep up with AI-driven commerce trends.